Javascript was detected to be disabled. Javascript is required for some functions on this website.

The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyze the economic dimension of health and health care, including research into the normative foundations and the methods of health economics, applied cost of illness and cost benefit studies, and their use in Health Technology Assessment (HTA).

Pixabay Grafik (#7562017)

Award-Winning Presentation

Ramon Schaefer received the Best General Poster Research Presentation Award at the ISPOR Europe 2023 Conference in Copenhagen, Denmark, November 12-15, 2023, for his presentation “What is a Year of Life Worth?".

Read more …

Speeding Up Innovation

Michael Schlander discussed best practices how to speed up innovation to patients at the 1st European Forum on the subject, held in Madrid, November 27, 2023, under the auspices of Pompeu Fabra University.

Read more …

Changing Perspectives on Value

Michael Schlander presented "Changing Perspectives on Value in HTA" at the 18th International EBHC Symposium in Krakow, Poland / October 09, 2023.

Read more …

The Role of Budget Impact in HTAs

Our research report on the impact of budget impact analyses on HTA-informed decisions by health care policy-makers appeared in “Value in Health” in July 2023.

Read more …

Textbook Release in 2023

Michael Schlander, Ramon Schäfer, Lorenz Selberg:

Nutzen der Labormedizin
in der Schweiz

Berlin, Heidelberg: Springer 2023
ISBN 978-3-662-66824-5 (Softcover)
ISBN 978-3-662-66825-2 (eBook)


While experts believe that 70 % of all clinical decisions depend on laboratory test information, the cost effectiveness of many diagnostic procedures is subject to controversial debate.
With this Open Access Book, we provide insight into the value of laboratory medicine from the perspectives of patients, public health, and society at large, using the Swiss health care system as a case study.